Cargando…
Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences
BACKGROUND: Ovarian cancer ascites fluid (OCAF), contains malignant cells, is usually present in women with an advanced stage disease and currently has no effective therapy. Hence, we developed a new therapy strategy to target the expression of diphtheria toxin gene under the control of H19 regulato...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734756/ https://www.ncbi.nlm.nih.gov/pubmed/19656414 http://dx.doi.org/10.1186/1479-5876-7-69 |
_version_ | 1782171204318134272 |
---|---|
author | Mizrahi, Aya Czerniak, Abraham Levy, Tally Amiur, Smadar Gallula, Jennifer Matouk, Imad Abu-lail, Rasha Sorin, Vladimir Birman, Tatiana de Groot, Nathan Hochberg, Abraham Ohana, Patricia |
author_facet | Mizrahi, Aya Czerniak, Abraham Levy, Tally Amiur, Smadar Gallula, Jennifer Matouk, Imad Abu-lail, Rasha Sorin, Vladimir Birman, Tatiana de Groot, Nathan Hochberg, Abraham Ohana, Patricia |
author_sort | Mizrahi, Aya |
collection | PubMed |
description | BACKGROUND: Ovarian cancer ascites fluid (OCAF), contains malignant cells, is usually present in women with an advanced stage disease and currently has no effective therapy. Hence, we developed a new therapy strategy to target the expression of diphtheria toxin gene under the control of H19 regulatory sequences in ovarian tumor cells. H19 RNA is present at high levels in human cancer tissues (including ovarian cancer), while existing at a nearly undetectable level in the surrounding normal tissue. METHODS: H19 gene expression was tested in cells from OCAF by the in-situ hybridization technique (ISH) using an H19 RNA probe. The therapeutic potential of the toxin vector DTA-H19 was tested in ovarian carcinoma cell lines and in a heterotopic animal model for ovarian cancer. RESULTS: H19 RNA was detected in 90% of patients with OCAF as determined by ISH. Intratumoral injection of DTA-H19 into ectopically developed tumors caused 40% inhibition of tumor growth. CONCLUSION: These observations may be the first step towards a major breakthrough in the treatment of human OCAF, while the effect in solid tumors required further investigation. It should enable us to identify likely non-responders in advance, and to treat patients who are resistant to all known therapies, thereby avoiding treatment failure. |
format | Text |
id | pubmed-2734756 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27347562009-08-29 Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences Mizrahi, Aya Czerniak, Abraham Levy, Tally Amiur, Smadar Gallula, Jennifer Matouk, Imad Abu-lail, Rasha Sorin, Vladimir Birman, Tatiana de Groot, Nathan Hochberg, Abraham Ohana, Patricia J Transl Med Research BACKGROUND: Ovarian cancer ascites fluid (OCAF), contains malignant cells, is usually present in women with an advanced stage disease and currently has no effective therapy. Hence, we developed a new therapy strategy to target the expression of diphtheria toxin gene under the control of H19 regulatory sequences in ovarian tumor cells. H19 RNA is present at high levels in human cancer tissues (including ovarian cancer), while existing at a nearly undetectable level in the surrounding normal tissue. METHODS: H19 gene expression was tested in cells from OCAF by the in-situ hybridization technique (ISH) using an H19 RNA probe. The therapeutic potential of the toxin vector DTA-H19 was tested in ovarian carcinoma cell lines and in a heterotopic animal model for ovarian cancer. RESULTS: H19 RNA was detected in 90% of patients with OCAF as determined by ISH. Intratumoral injection of DTA-H19 into ectopically developed tumors caused 40% inhibition of tumor growth. CONCLUSION: These observations may be the first step towards a major breakthrough in the treatment of human OCAF, while the effect in solid tumors required further investigation. It should enable us to identify likely non-responders in advance, and to treat patients who are resistant to all known therapies, thereby avoiding treatment failure. BioMed Central 2009-08-06 /pmc/articles/PMC2734756/ /pubmed/19656414 http://dx.doi.org/10.1186/1479-5876-7-69 Text en Copyright © 2009 Mizrahi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Mizrahi, Aya Czerniak, Abraham Levy, Tally Amiur, Smadar Gallula, Jennifer Matouk, Imad Abu-lail, Rasha Sorin, Vladimir Birman, Tatiana de Groot, Nathan Hochberg, Abraham Ohana, Patricia Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences |
title | Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences |
title_full | Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences |
title_fullStr | Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences |
title_full_unstemmed | Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences |
title_short | Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences |
title_sort | development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of h19 regulatory sequences |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734756/ https://www.ncbi.nlm.nih.gov/pubmed/19656414 http://dx.doi.org/10.1186/1479-5876-7-69 |
work_keys_str_mv | AT mizrahiaya developmentoftargetedtherapyforovariancancermediatedbyaplasmidexpressingdiphtheriatoxinunderthecontrolofh19regulatorysequences AT czerniakabraham developmentoftargetedtherapyforovariancancermediatedbyaplasmidexpressingdiphtheriatoxinunderthecontrolofh19regulatorysequences AT levytally developmentoftargetedtherapyforovariancancermediatedbyaplasmidexpressingdiphtheriatoxinunderthecontrolofh19regulatorysequences AT amiursmadar developmentoftargetedtherapyforovariancancermediatedbyaplasmidexpressingdiphtheriatoxinunderthecontrolofh19regulatorysequences AT gallulajennifer developmentoftargetedtherapyforovariancancermediatedbyaplasmidexpressingdiphtheriatoxinunderthecontrolofh19regulatorysequences AT matoukimad developmentoftargetedtherapyforovariancancermediatedbyaplasmidexpressingdiphtheriatoxinunderthecontrolofh19regulatorysequences AT abulailrasha developmentoftargetedtherapyforovariancancermediatedbyaplasmidexpressingdiphtheriatoxinunderthecontrolofh19regulatorysequences AT sorinvladimir developmentoftargetedtherapyforovariancancermediatedbyaplasmidexpressingdiphtheriatoxinunderthecontrolofh19regulatorysequences AT birmantatiana developmentoftargetedtherapyforovariancancermediatedbyaplasmidexpressingdiphtheriatoxinunderthecontrolofh19regulatorysequences AT degrootnathan developmentoftargetedtherapyforovariancancermediatedbyaplasmidexpressingdiphtheriatoxinunderthecontrolofh19regulatorysequences AT hochbergabraham developmentoftargetedtherapyforovariancancermediatedbyaplasmidexpressingdiphtheriatoxinunderthecontrolofh19regulatorysequences AT ohanapatricia developmentoftargetedtherapyforovariancancermediatedbyaplasmidexpressingdiphtheriatoxinunderthecontrolofh19regulatorysequences |